Close

April 29, 2019

Our research on drug delivery to treat peritoneal cancer is highlighted in Elsevier, Eindhovens Dagblad and Studio040

The research by Peter-Paul Fransen and Geert van Almen in collaboration with Maastricht UMC+ and Catarina Hospital Eindhoven, which is sponsored by KWF (Dutch Cancer Society), on the development of a hydrogel which incapsulates anti-cancer drugs targeting peritoneal cancer was featured in Elsevier Weekblad, Eindhovens Dagblad and Studio040 last week alongside a short video explaining the concept. The gels show promising results in vitro where it effectively kills the specific cancer cells. The next step is testing the gels in animal models and if this has proven successfully the step after would be clinical trials.
The articles can be read here in Dutch:
Injecteerbare chemogel in de strijd tegen kanker in de buik (Elsevier)
Slimme gel TU/e biedt hoop bij buikvlieskanker (Eindhovens Dagblad)
TU Eindhoven ontwikkelt ‘chemo-gel’ tegen buikvlieskanker (Studio040)